TRANSMEDICS GROUP INC (TMDX:NASDAQ)
$72.91 -0.68 (-0.924%)
Analysed TRANSMEDICS GROUP INC (TMDX:NASDAQ) News Sources
TMDX Dips After Posting Q1 Earnings & Revenue Miss, Margins Fall
06-05-2026
yahoo.com
My Top 3 Stocks to Buy in May
07-05-2026
fool.com
Glucotrack Submits Blood Glucose Monitoring Technology to FDA
07-05-2026
yahoo.com
TransMedics Group Inc (TMDX) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...
08-05-2026
yahoo.com
Assessing TransMedics Group (TMDX) Valuation After A Sharp One Year Share Price Decline
10-05-2026
yahoo.com
TransMedics to Present at the William Blair 46th Annual Growth Stock Conference
19-05-2026
yahoo.com
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
21-05-2026
yahoo.com
Reasons to Retain TransMedics Stock in Your Portfolio for Now
28-05-2026
yahoo.com
TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound?
04-06-2026
yahoo.com
Will Analyst Focus on TransMedics’ OCS Platform and Financial Metrics Change TransMedics Group’s (TMDX) Narrative?
06-06-2026
yahoo.com
What is the current price of TRANSMEDICS GROUP INC (TMDX:NASDAQ)?
The current price of TRANSMEDICS GROUP INC (TMDX:NASDAQ) is $72.91.
TRANSMEDICS GROUP INC (TMDX:NASDAQ) absolute price change since previous trading day?
The absolute price change of TRANSMEDICS GROUP INC (TMDX:NASDAQ) since the previous trading day is $-0.68.
TRANSMEDICS GROUP INC (TMDX:NASDAQ) percentage price change since previous trading day?
The percentage price change of TRANSMEDICS GROUP INC (TMDX:NASDAQ) since the previous trading day is -0.924%.
What is the most recent average sentiment score for TRANSMEDICS GROUP INC (TMDX:NASDAQ)?
The most recent average sentiment score for TRANSMEDICS GROUP INC (TMDX:NASDAQ) is 64 out of 100.
What is the most recent average sentiment for TRANSMEDICS GROUP INC (TMDX:NASDAQ)?
The most recent sentiment for TRANSMEDICS GROUP INC (TMDX:NASDAQ) is .
SEC-8K** Filing Available For TRANSMEDICS GROUP INC (TMDX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.